What is Ipamorelin?
Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). In research it is valued for being one of the most selective GHRPs, reported to stimulate GH release with minimal effect on cortisol or prolactin compared with older GHRPs.
How is Ipamorelin studied in equine research?
In equine veterinary research, Ipamorelin is studied as a model compound for selective gh-release research. The horse is one of the most-studied large-animal models in connective-tissue and musculoskeletal research because equine tendon and ligament injuries are common and slow to resolve. Peptides associated with angiogenesis and tissue repair, such as BPC-157 and TB-500 (Thymosin Beta-4), appear frequently in equine-model research literature for exactly this reason.
Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.
Sourcing, purity & COA for Horses Ipamorelin research
Every lot supplied for Horses Ipamorelin research is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC. A Certificate of Analysis is available on request and ties each vial to a tracked lot. We ship nationwide to veterinary and university research programs with cold-chain handling where appropriate. Publicly verifiable third-party documentation is the trust standard for serious veterinary research material.
Frequently asked questions
Is Ipamorelin studied in equine research?
Ipamorelin appears in equine research models as a model compound (A selective growth-hormone-releasing peptide studied for clean GH-pulse research.). It is research-use-only and not for administration to horses. Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.
Is Ipamorelin approved for horses?
No. Ipamorelin is not approved by the FDA for veterinary use and is supplied strictly for laboratory and veterinary research, not for administration to any animal. All material is research-use-only, is not for administration to horses or any other animal, is not for food-producing animals, and is not veterinary medical advice.
What sizes of Ipamorelin are available?
Ipamorelin ships as lyophilized research vials (5 mg vial, 10 mg vial), third-party tested with a COA on request. Ipamorelin is supplied as a lyophilized (freeze-dried) powder in 5 mg and 10 mg research sizes. Material ships nationwide to qualified research programs in all 50 US states as stable lyophilized vials, with cold-chain handling where appropriate.
Can veterinary researchers order Ipamorelin B2B?
Yes - we supply qualified veterinary researchers and facilities B2B and via the research portal. Every lot is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request.
How is Ipamorelin purity verified for equine research?
Purity is verified by an independent third-party laboratory: HPLC quantifies purity against a 99%+ target and mass spectrometry confirms identity. The resulting Certificate of Analysis is tied to the tracked lot of the vial you receive and is available on request, so equine study records stay traceable.
How is Ipamorelin stored for research?
Un-reconstituted Ipamorelin vials are stored refrigerated and protected from light; the lyophilized powder is stable enough to tolerate shipping. After reconstitution to a defined concentration, research solutions are kept at 2-8C, away from light, and used within roughly two to four weeks, labeled with concentration and date.
All horses research peptides · Ipamorelin overview
External references: FDA Center for Veterinary Medicine · Peptide (Wikipedia)